Treace Medical Concepts Presents Robust Clinical Evidence at AOFAS 2026
News related to:Treace Medical Concepts, Inc · 3 min read
PONTE VEDRA, Fla., Sept. 17, 2026 /CourierPR/ -- Treace Medical Concepts, a company driving innovation in the surgical treatment of bunions and other foot and ankle conditions, has presented robust clinical evidence at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Seattle, Washington. The company's flagship procedures and technologies have been validated through three clinical studies, including the milestone 5-year ALIGN3D® Lapiplasty® study.
The 5-year ALIGN3D® Lapiplasty® clinical study, presented by Daniel Farber, MD, from Lehigh Valley Orthopedic Institute, included final analysis of 137 of 173 total patients treated with the Lapiplasty® Procedure. The study showed that patients returned to weight-bearing in a walking boot at an average of 8.4 days. Radiographic recurrence rates were low, with 0.8% using HVA>20° and 5.3% using HVA>15° at 5 years. Clinically, there was a significant reduction in patient-reported scores (MOxFQ and PROMIS) through the five-year follow-up period.
The MTA3D® Adductoplasty® clinical study, presented by Mark Easley, MD, from Duke University, included interim analysis of 59 of 66 and 35 of 66 patients treated with at least one- and two-year follow-up, respectively. Patients returned to weight-bearing in a walking boot at an average of 7.6 days. The study demonstrated clinically significant improvement and maintenance of radiographic measures of both midfoot (metatarsus adductus) and 3D bunion correction through 24 months. Additionally, there was a clinically significant reduction in pain and patient-reported scores (VAS, MOxFQ, and PROMIS) through 24 months.
The SPRINT™ SpeedPlate® observational study, presented by Jody McAleer, DPM, from Jefferson City Medical Group, included final analysis of 89 of 91 total patients following MTP and/or TMT joint arthrodesis using SpeedPlate® Rapid Compression Implants. Patients returned to weight-bearing in a walking boot at an average of 9.0 days. High union rates with clinical and radiographic healing were observed in 96.6% of patients at 12 months. The study also showed clinically significant improvements in radiographic correction (HVA, IMA, TSP, Osseous Foot Width) at 6 weeks and maintained through 12 months in patients with hallux valgus.
The ALIGN3D™ clinical study, a prospective, multicenter, post-market clinical study, evaluated outcomes of the Lapiplasty® 3D Bunion Correction® procedure in the surgical management of symptomatic hallux valgus. The study enrolled 173 patients, aged 14 to 58 years, at 7 clinical sites in the United States with 13 participating surgeons. Final patient follow-up for the primary endpoint was completed in the first half of 2023, and study completion with 5-year data was completed in 2026.
The MTA3D® clinical study, a prospective, multicenter, post-market study, evaluated the combined Adductoplasty® and Lapiplasty® Procedures for patients in need of metatarsus adductus and hallux valgus corrective surgery. The study treated up to 66 patients, aged 14 years and up, at 7 clinical sites in the United States. Patients will be followed for 2 years following the procedures.
The SPRINT™ clinical study, an ambirectional, multicenter, post-market study, evaluated the healing/union rates following joint fixation using the SpeedPlate® Rapid Compression Implants and whether early weight-bearing following joint fixation affects the healing/union rates. The study included 91 treated patients, aged 14 years and up, at 5 clinical sites in the United States. Patients were followed for 1 year following the procedure.
Treace Medical Concepts, Inc., a company with the goal of being the recognized leader in the surgical treatment of bunions and other foot and ankle conditions, has pioneered and patented the Lapiplasty® 3D Bunion Correction® System. The company continues to expand its footprint in the marketplace by extending its SpeedPlate® rapid compression implant platform to new applications and offering advanced digital solutions with its IntelliGuide® patient-specific, pre-op planning and cut guide technology.